In summary, our proteomic study revealed alterations in the proteomic plasma profiles between NPDR+DKD and NPDR patients, in particular validating the roles of VIM and B2M in NPDR patients with DKD. The gene discussed is B2M; the disease is non-proliferative diabetic retinopathy.